Medical News

RSS

$CTI files SPA with FDA for new pixantrone phase III trial in relapsed or refractory aggressive B-Cell NHL$

CTI files SPA with FDA for new pixantrone phase III trial in relapsed or refractory aggressive B-Cell NHL

Cell Therapeutics, Inc. today announced it has filed for a Special Protocol Assessment ("SPA") with the U.S. Food and Drug Administration ("FDA") for the design of its new phase III trial of pixantrone for patients with relapsed or refractory aggressive B-Cell non-Hodgkin's lymphoma ("NHL").

4 Aug 2010

Study solves puzzle behind different types of skin cancer on different body parts

A consistent all-over tan may be impossible to achieve because some body areas are much more resistant to tanning than others, a study has found.Researchers - funded by the Medical Research Council (MRC) - at the University of Edinburgh say the results explain why some holidaymakers find it so hard to achieve an even tan all over their body.

4 Aug 2010

WebMD second-quarter adjusted EBITDA increases 71% to $34.3 million

WebMD Health Corp., the leading source of health information, today announced financial results for the three months ended June 30, 2010.

4 Aug 2010

Premier international conference to discuss latest diagnostic tools, emerging therapies for personalized medicine

What As scientists understand more about a tumor's underlying biology, personalized medicine is emerging as the new patient management paradigm. This year, the American Association for Cancer Research will host its fourth Molecular Diagnostics in Cancer Therapeutic Development: Challenges and Horizons conference at the Sheraton Denver Downtown Hotel in Denver, Colo. This meeting regularly draws representatives from academia and industry to discuss the latest in diagnostic tools and emerging therapies.

4 Aug 2010

New York lawmakers trying to revive 9/11 health care bill

Lawmakers are trying to bridge the gap between colleagues on the left and right in a bid to provide greater health coverage for 9/11 workers, The Wall Street Journal reports. "The bill was voted down [in the House] late Thursday night amid angry partisan finger-pointing, and now Democratic Rep. Carolyn Maloney and others have begun weighing options to make the bill more tolerable to factions on the right and left. … Already, Democrats are signaling a shift in strategy.

4 Aug 2010

Dendreon to implement Pilgrim's Deviation and Corrective and Preventive Action management system

Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.

4 Aug 2010

International conference to discuss research, unresolved issues of sickle cell disease

Carlton Haywood Jr., Ph.D., an associate faculty member of the Johns Hopkins Berman Institute of Bioethics, will mark the 100-year anniversary of the discovery of sickle cell anemia on Wednesday, Aug. 4, with a talk on the impact that race has had on the history of research and treatment of the inherited blood disorder.

4 Aug 2010

RehabCare second-quarter consolidated operating revenues increase 62.8% to $334.0 million

RehabCare Group, Inc. today reported financial results for the quarter and six months ended June 30, 2010. Comparative results for the quarter and six months follow.

4 Aug 2010

Senate to debate bill to stop violence against women

"Bipartisan legislation that would mandate a comprehensive plan to combat violence against women worldwide is poised for a potential congressional vote, marking tough new action by the United States on a problem that's commonplace across the globe," McClatchy Newspapers reports.

4 Aug 2010

RBC Life Sciences company-wide net sales rises to $7.8 million in second quarter

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, today reported company-wide net sales of $7.8 million for the second quarter ended June 30, 2010, compared to net sales of $6.8 million for the same period during 2009, an increase of 16%. Net sales for the six months ended June 30, 2010 also increased 16% to $14.8 million compared to net sales of $12.8 million during the same period in 2009.

4 Aug 2010

European Commission grants Teva approval for acquisition of ratiopharm

Teva Pharmaceutical Industries Ltd. announced today that the Company received approval from the European Commission to proceed with its acquisition of ratiopharm.

4 Aug 2010

Smokers are 11 times more likely to develop subareolar abscess

Women who smoke or pierce their nipples are more likely to develop a breast abscess, according to a new study in the July issue of the Journal of the American College of Surgeons. Researchers at the University of Iowa found the odds of developing primary breast abscess were six times higher in smokers than in nonsmokers, and smokers were 11 times more likely to develop subareolar abscess. Breast abscesses were 15 times more likely to recur in smokers than in nonsmokers. In addition, this study is one of the first to provide clinical evidence that nipple piercing is also a risk factor for subareolar breast abscess, with the onset of abscess occurring from one month to seven years from the time of piercing.

4 Aug 2010

ZymoGenetics second-quarter net loss declines to $3.8 million

ZymoGenetics, Inc. today reported substantially improved financial results for the quarter ended June 30, 2010. For the second quarter of 2010, the company's net loss declined to $3.8 million, or $0.04 per share, a $23.2 million improvement from the $27.0 million loss, or $0.39 per share, reported for the second quarter of 2009. The improvement resulted from higher revenues as well as reduced operating expenses.

4 Aug 2010

Hospitals, docs adopting health IT ahead of schedule

Clinics and hospitals are increasingly switching to electronic medical records as a federal push to spread the technology sweeps across the nation.

4 Aug 2010

Boston Scientific initiates enrollment in EVOLVE clinical trial of SYNERGY Coronary Stent

Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.

4 Aug 2010

Scientists identify IRP proteins to ensure iron balance for cell survival

Most organisms need iron to survive, but too much iron is toxic, and can cause fatal organ failure. The same is true inside cells, where iron balance must also be maintained. In a study published today in Cell Metabolism, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have discovered that a group of proteins named IRPs ensure that this iron balance is kept and as such are essential for cell survival. More specifically, they found that IRPs are required for the functioning of mitochondria, the cell's energy factories.

4 Aug 2010

SVH launches Guiding Stars nutrition guidance program

The highly regarded Guiding Stars nutrition guidance program - now available in more than 1,500 grocery stores and schools - today announces its partnership with Sebasticook Valley Hospital (SVH) in Pittsfield, Maine to launch the nutrition guidance program in a hospital for the first time. Guiding Stars will rate prepared meals, snacks, and grab-and-go items according to their nutritional value in the hospital cafeteria. Each item rated will receive zero to three stars for an at-a-glance summary of the food's nutritional quality.

4 Aug 2010

BCM collaborates with Roche NimbleGen for high throughput exome capture technology

The Baylor College of Medicine Human Genome Sequencing Center has standardized its target enrichment human disease research studies on Roche NimbleGen Sequence Capture Exome technology. The Baylor HGSC will sequence over 5,000 exomes in the next two years to identify genetic variants underlying multiple human diseases and will employ NimbleGen SeqCap EZ Exome and customized NimbleGen exome designs as the exome capture technology of choice. More than 15 different diseases will be investigated by Baylor HGSC, including brain, liver, pancreatic, colon, ovarian and bladder cancers, heart disease, diabetes, autism, and other inherited diseases with the goal of better understanding causative mutations and their impact on these diseases.

4 Aug 2010

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

4 Aug 2010

Missourians vote today on health reform ballot initiative

Missouri voters Tuesday are weighing in on a ballot measure that would ban laws from requiring people to have insurance in a vote that is sure to send a political message but may not have much legal impact, The Associated Press/Columbia Missourian reports. "If it passes as expected, the Missouri measure could send a troublesome signal from a historical swing-state about the most high-profile accomplishment of Obama and the Democratic-led Congress." If it fails, Republicans will get burnt on an issue they have sought to pull into mid-term elections.

4 Aug 2010

Medical News

CTI files SPA with FDA for new pixantrone phase III trial in relapsed or refractory aggressive B-Cell NHL

Study solves puzzle behind different types of skin cancer on different body parts

WebMD second-quarter adjusted EBITDA increases 71% to $34.3 million

Premier international conference to discuss latest diagnostic tools, emerging therapies for personalized medicine

New York lawmakers trying to revive 9/11 health care bill

Dendreon to implement Pilgrim's Deviation and Corrective and Preventive Action management system

International conference to discuss research, unresolved issues of sickle cell disease

RehabCare second-quarter consolidated operating revenues increase 62.8% to $334.0 million

Senate to debate bill to stop violence against women

RBC Life Sciences company-wide net sales rises to $7.8 million in second quarter

European Commission grants Teva approval for acquisition of ratiopharm

Smokers are 11 times more likely to develop subareolar abscess

ZymoGenetics second-quarter net loss declines to $3.8 million

Hospitals, docs adopting health IT ahead of schedule

Boston Scientific initiates enrollment in EVOLVE clinical trial of SYNERGY Coronary Stent

Scientists identify IRP proteins to ensure iron balance for cell survival

SVH launches Guiding Stars nutrition guidance program

BCM collaborates with Roche NimbleGen for high throughput exome capture technology

Dendreon second-quarter revenue increases to $2.8 million

Missourians vote today on health reform ballot initiative

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News